Foros de Conocimiento
medtronic PRODUCTOS
boston_scientific PRODUCTOS
TERUMO PRODUCTOS
Biotronik PRODUCTOS
Sirtex PRODUCTOS
Striker Neurovascular PRODUCTOS
BIOSENSORS PRODUCTOS

ESTUDIOS


01 diciembre 2017

JACC: CARDIOVASCULAR INTERVENTIONS. Incidence, Prognostic Impact, and Predictive Factors of Readmission for Heart Failure After Transcatheter Aortic Valve Replacement

Eric Durand, Maxime Doutriaux, Nicolas Bettinger, Christophe Tron, Charles Fauvel, Fabrice Bauer, Jean-Nicolas Dacher, Najime Bouhzam, Pierre-Yves Litzler, Alain Cribier and Hélène Eltchaninoff

Objectives: The aim of this study was to assess the incidence, prognostic impact, and predictive factors of readmission for congestive heart failure (CHF) in patients with severe aortic stenosis treated by transcatheter aortic valve replacement (TAVR).

01 diciembre 2017

JACC: CARDIOVASCULAR INTERVENTIONS. Transapical Transcatheter Aortic Valve Replacement Is Associated With Increased Cardiac Mortality in Patients With Left Ventricular Dysfunction

Sammy Elmariah, William F. Fearon, Ignacio Inglessis, Gus J. Vlahakes, Brian R. Lindman, Maria C. Alu, Aaron Crowley, Susheel Kodali, Martin B. Leon, Lars Svensson, Philippe Pibarot, Rebecca T. Hahn, Vinod H. Thourani, Igor F. Palacios, D. Craig Miller, Pamela S. Douglas, Jonathan J. Passeri and on behalf of the PARTNER Trial Investigators and PARTNER Publications Office

Objectives: The authors sought to evaluate the impact of transapical (TA) transcatheter aortic valve replacement (TAVR) on mortality, left ventricular (LV) ejection fraction (LVEF) improvement, and functional recovery in patients with LV dysfunction.

01 diciembre 2017

JACC: CARDIOVASCULAR INTERVENTIONS. The DELTA 2 Registry: A Multicenter Registry Evaluating Percutaneous Coronary Intervention With New-Generation Drug-Eluting Stents in Patients With Obstructive Left Main Coronary Artery Disease

Alaide Chieffo, Akihito Tanaka, Gennaro Giustino, Ieva Briede, Fadi J. Sawaya, Joost Daemen, Hiroyoshi Kawamoto, Emanuele Meliga, Fabrizio D’Ascenzo, Enrico Cerrato, Giulio G. Stefanini, Davide Capodanno, Andrea Mangiameli, Christian Templin, Andrejs Erglis, Marie Claude Morice, Roxana Mehran, Nicolas M. Van Mieghem, Sunao Nakamura, Mauro De Benedictis, Marco Pavani, Ferdinando Varbella, Marco Pisaniello, Samin K. Sharma, Corrado Tamburino, Didier Tchetche, Antonio Colombo and on behalf of the DELTA 2 Investigators

Objectives: The aim of this study was to evaluate clinical outcomes of unprotected left main coronary artery percutaneous coronary intervention (PCI) with new-generation drug-eluting stents in a “real world” population.

01 diciembre 2017

JACC: CARDIOVASCULAR INTERVENTIONS. Long-Term Safety and Efficacy of Platinum Chromium Everolimus-Eluting Stents in Coronary Artery Disease

Christopher R. Kelly, Paul S. Teirstein, Ian T. Meredith, Bruno Farah, Christophe L. Dubois, Robert L. Feldman, Joseph Dens, Nobuhisa Hagiwara, Abram Rabinowitz, Didier Carrié, Vincent Pompili, Alain Bouchard, Shigeru Saito, Dominic J. Allocco, Keith D. Dawkins and Gregg W. Stone

Objectives: The authors sought to evaluate the final 5-year safety and effectiveness of the platinum-chromium everolimus-eluting stent (PtCr-EES) in the randomized trial, as well as in 2 single-arm substudies that evaluated PtCr-EES in small vessels (diameter <2.5 mm; n = 94) and long lesions (24 to 34 mm; n = 102).

01 diciembre 2017

JACC: CARDIOVASCULAR INTERVENTIONS. Endothelial Barrier Protein Expression in Biodegradable Polymer Sirolimus-Eluting Versus Durable Polymer Everolimus-Eluting Metallic Stents

Hiroyoshi Mori, Qi Cheng, Christoph Lutter, Samantha Smith, Liang Guo, Matthew Kutyna, Sho Torii, Emanuel Harari, Eduardo Acampado, Michael Joner, Frank D. Kolodgie, Renu Virmani and Aloke V. Finn

Objectives: This study sought to investigate endothelial coverage and barrier protein expression following stent implantation.

01 diciembre 2017

JACC: CARDIOVASCULAR INTERVENTIONS. Characteristics, Predictors, and Mechanisms of Thrombosis in Coronary Bioresorbable Scaffolds: Differences Between Early and Late Events

Tommaso Gori, Melissa Weissner, Svenja Gönner, Franziska Wendling, Helen Ullrich, Stephen Ellis, Remzi Anadol, Alberto Polimeni and Thomas Münzel

Objectives: The study sought to investigate the incidence, characteristics, predictors, and possible mechanisms of early and 3-year coronary scaffold thrombosis (ScT).

01 diciembre 2017

JACC: CARDIOVASCULAR INTERVENTIONS. Fractional Flow Reserve/Instantaneous Wave-Free Ratio Discordance in Angiographically Intermediate Coronary Stenoses

Christopher M. Cook, Allen Jeremias, Ricardo Petraco, Sayan Sen, Sukhjinder Nijjer, Matthew J. Shun-Shin, Yousif Ahmad, Guus de Waard, Tim van de Hoef, Mauro Echavarria-Pinto, Martijn van Lavieren, Rasha Al Lamee, Yuetsu Kikuta, Yasutsugu Shiono, Ashesh Buch, Martijn Meuwissen, Ibrahim Danad, Paul Knaapen, Akiko Maehara, Bon-Kwon Koo, Gary S. Mintz, Javier Escaned, Gregg W. Stone, Darrel P. Francis, Jamil Mayet, Jan J. Piek, Niels van Royen and Justin E. Davies

Objectives: The study sought to determine the coronary flow characteristics of angiographically intermediate stenoses classified as discordant by fractional flow reserve (FFR) and instantaneous wave-free ratio (iFR).

01 diciembre 2017

JACC: CARDIOVASCULAR INTERVENTIONS. Observational Study of Platelet Reactivity in Patients Presenting With ST-Segment Elevation Myocardial Infarction Due to Coronary Stent Thrombosis Undergoing Primary Percutaneous Coronary Intervention

Thea C. Godschalk, Robert A. Byrne, Tom Adriaenssens, Nikesh Malik, Laurent J. Feldman, Giulio Guagliumi, Fernando Alfonso, Franz-Josef Neumann, Dietmar Trenk, Michael Joner, Christian Schulz, Philippe G. Steg, Alison H. Goodall, Roman Wojdyla, Dariusz Dudek, Joanna J. Wykrzykowska, Ota Hlinomaz, Azfar G. Zaman, Nick Curzen, Jo Dens, Peter Sinnaeve, Walter Desmet, Anthony H. Gershlick, Adnan Kastrati, Steffen Massberg, Jurriën M. ten Berg and on behalf of the PRESTIGE Investigators

Objectives: High platelet reactivity (HPR) was studied in patients presenting with ST-segment elevation myocardial infarction (STEMI) due to stent thrombosis (ST) undergoing immediate percutaneous coronary intervention (PCI).

01 noviembre 2017

JACC: CARDIOVASCULAR INTERVENTIONS. Intracardiac Echocardiography From the Left Atrium for Procedural Guidance of Transcatheter Left Atrial Appendage Occlusion

Kasper Korsholm, Jesper Møller Jensen and Jens Erik Nielsen-Kudsk

Objectives: The aim of this study was to compare the efficacy and safety of intracardiac echocardiography (ICE) from the left atrium (LA) with transesophageal echocardiography (TEE) for procedural guidance of transcatheter left atrial appendage occlusion (LAAO).

01 noviembre 2017

JACC: CARDIOVASCULAR INTERVENTIONS. Percutaneous Coronary Intervention of Chronic Total Occlusions in Patients With Low Left Ventricular Ejection Fraction

Alfredo R. Galassi, Marouane Boukhris, Aurel Toma, Zied Ibn Elhadj, Lobna Laroussi, Oliver Gaemperli, Michael Behnes, Ibrahim Akin, Thomas F. Lüscher, Franz J. Neumann and Kambis Mashayekhi

Objectives: The study sought to assess the outcome of percutaneous coronary intervention (PCI) of chronic total occlusions (CTOs) in patients with low left ventricular ejection fraction (LVEF) (≤35%).

01 noviembre 2017

JACC: CARDIOVASCULAR INTERVENTIONS. Outcomes of Chronic Total Occlusion Percutaneous Coronary Intervention in Patients With Diabetes

Adam C. Salisbury, James Sapontis, J. Aaron Grantham, Mohammed Qintar, Kensey L. Gosch, William Lombardi, Dimitri Karmpaliotis, Jeffrey Moses, David J. Cohen, John A. Spertus, Mikhail Kosiborod and for the OPEN CTO Study Group

Objectives: Few studies have evaluated the relationship of diabetes with technical success and periprocedural complications, and no studies have compared patient-reported health status after chronic total occlusion (CTO) percutaneous coronary intervention (PCI) in patients with and without diabetes.

01 noviembre 2017

JACC: CARDIOVASCULAR INTERVENTIONS. Long-Term Health Benefit of Transcatheter Aortic Valve Replacement in Patients With Chronic Lung Disease

Juan A. Crestanello, Jeffrey J. Popma, David H. Adams, G. Michael Deeb, Mubashir Mumtaz, Barry George, Jian Huang and Michael J. Reardon

Objectives: This study sought to characterize the long-term effect of chronic lung disease (CLD) on mortality, clinical outcomes, quality of life, and health benefits after transcatheter aortic valve replacement (TAVR) with a self-expanding bioprosthesis.

Utilizamos cookies propias para el correcto funcionamiento del sitio web y mejorar nuestros servicios. Pulse el botón Aceptar todas para aceptar su uso. Puede cambiar la configuración u obtener más información en nuestra Política de cookies o pulsando Modificar configuración.